Ocugen(OCGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCGN Ocugen

交易中 12-29 10:06:18 EST

1.40

-0.01

-1.00%

最高1.42	最低1.39	成交量38.29万
今开1.39	昨收1.41	日振幅2.48%
总市值4.36亿	流通市值4.28亿	总股本3.12亿
成交额53.53万	换手率0.12%	流通股本3.07亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCGN","market":"US","secType":"STK","nameCN":"Ocugen","latestPrice":1.3959,"timestamp":1767020765285,"preClose":1.41,"halted":0,"volume":382905,"delay":0,"floatShares":306730373,"shares":312320112,"eps":-0.217151,"marketStatus":"交易中","change":-0.0141,"latestTime":"12-29 10:06:18 EST","open":1.39,"high":1.42,"low":1.385,"amount":535283.040303,"amplitude":0.024823,"askPrice":1.4,"askSize":3470,"bidPrice":1.39,"bidSize":3455,"shortable":3,"etf":0,"ttmEps":-0.217151,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1767042000000},"marketStatusCode":2,"adr":0,"listingDate":1417582800000,"exchange":"NASDAQ","adjPreClose":1.41,"preHourTrading":{"tag":"盘前","latestPrice":1.39,"preClose":1.41,"latestTime":"09:29 EST","volume":17142,"amount":23887.7078406,"timestamp":1767018599910},"postHourTrading":{"tag":"盘后","latestPrice":1.3999,"preClose":1.41,"latestTime":"19:57 EST","volume":23184,"amount":32447.4853,"timestamp":1766797022777},"volumeRatio":1.099497,"impliedVol":0.8356,"impliedVolPercentile":0.196},"requestUrl":"/m/hq/s/OCGN","defaultTab":"news","newsList":[{"id":"1138163725","title":"Ocugen第三季度运营利润为-1762.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138163725","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138163725?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:40","pubTimestamp":1763570429,"startTime":"0","endTime":"0","summary":"11月5日（路透社）- Ocugen第三季度收入为175.2万美元，而IBES预期为55万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4568","OCGN"],"gpt_icon":0},{"id":"1112062863","title":"Ocugen 2025年第三季度业绩会总结及问答精华：基因疗法进展与全球市场布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1112062863","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112062863?lang=zh_cn&edition=full","pubTime":"2025-11-06 00:16","pubTimestamp":1762359385,"startTime":"0","endTime":"0","summary":"OCU410的欧洲监管接受美国试验设计，简化了提交时间表。韩国的监管机构预计将在美国授权后迅速进入市场。OCU410SD的二至三期中期数据预计将在2026年中期公布。截至2025年9月30日，公司现金余额为3290万美元，第三季度融资后预计运营资金可持续至2026年。Ocugen在基因疗法领域取得了显著进展，特别是在OCU400和OCU410的开发和市场准备方面。尽管面临一些风险，管理层对未来的商业化和临床进展充满信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCGN"],"gpt_icon":0},{"id":"1130974844","title":"Ocugen公司：将在2026年第一季度发布Ocu410二期临床试验的完整数据，并于2026年开始三期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1130974844","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130974844?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:32","pubTimestamp":1762342357,"startTime":"0","endTime":"0","summary":"Ocugen公司：将在2026年第一季度发布Ocu410二期临床试验的完整数据，并于2026年开始三期试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","BK4563","OCGN"],"gpt_icon":0},{"id":"2570038969","title":"Ocugen, Inc.盘中异动 快速拉升6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570038969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570038969?lang=zh_cn&edition=full","pubTime":"2025-09-24 21:42","pubTimestamp":1758721350,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日21时42分，Ocugen, Inc.股票出现波动，股价急速上涨6.02%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Uniqure N.V.、Osr Holdings Inc C/Wts 09/02/2028 、Cyclerion Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Jaguar Health, Inc.、Uniqure N.V.较为活跃，换手率分别为345.75%、35.37%、27.21%，振幅较大的相关个股有Uniqure N.V.、Pharmacyte  Biotech, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为35.58%、28.69%、20.87%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924214230a4413ff2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924214230a4413ff2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4563","OCGN"],"gpt_icon":0},{"id":"1135309654","title":"Ocugen公司与韩国广东制药完成OCU400视网膜色素变性调节性基因疗法许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1135309654","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135309654?lang=zh_cn&edition=full","pubTime":"2025-09-15 18:04","pubTimestamp":1757930679,"startTime":"0","endTime":"0","summary":"Ocugen公司与韩国广东制药株式会社宣布完成OCU400调节性基因疗法的许可协议，该疗法用于治疗视网膜色素变性疾病，协议涵盖韩国市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","OCGN","BK4568","BK4139"],"gpt_icon":0},{"id":"2558502923","title":"Ocugen, Inc.2025财年第二财季实现净利润-14.74百万美元，同比增加3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558502923","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558502923?lang=zh_cn&edition=full","pubTime":"2025-08-10 00:01","pubTimestamp":1754755284,"startTime":"0","endTime":"0","summary":"8月10日，Ocugen, Inc.公布财报，公告显示公司2025财年第二财季净利润为-14.74百万美元，同比增加3.53%；其中营业收入为1.37百万美元，同比增加20.18%，每股基本收益为-0.05美元。从资产负债表来看，Ocugen, Inc.总负债50.54百万美元，其中短期债务853000.00美元，资产负债比为1.07，流动比率为1.83。机构评级：截至2025年8月10日，当前有4家机构对Ocugen, Inc.目标价做出预测，其中目标均价为6.50美元，其中最低目标价为4.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000311a6dcb823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000311a6dcb823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN"],"gpt_icon":0},{"id":"2557934555","title":"Ocugen, Inc.盘中异动 下午盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557934555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557934555?lang=zh_cn&edition=full","pubTime":"2025-08-08 03:00","pubTimestamp":1754593219,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日03时00分，Ocugen, Inc.股票出现异动，股价急速上涨5.39%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 、C4 Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1854.60%、221.52%、110.79%，振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ，振幅分别为105.51%、82.50%、59.72%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080803001994d61957&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080803001994d61957&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","OCGN","BK4563"],"gpt_icon":0},{"id":"2557319954","title":"Ocugen, Inc.盘中异动 临近收盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557319954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557319954?lang=zh_cn&edition=full","pubTime":"2025-08-06 03:44","pubTimestamp":1754423058,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日03时44分，Ocugen, Inc.股票出现波动，股价急速下挫5.00%。截至发稿，该股报0.950美元/股，成交量295.659万股，换手率1.01%，振幅5.97%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为3.70%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060344189735eaf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060344189735eaf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4568","OCGN"],"gpt_icon":0},{"id":"2555025683","title":"Ocugen, Inc.盘中异动 快速拉升6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555025683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555025683?lang=zh_cn&edition=full","pubTime":"2025-07-31 00:34","pubTimestamp":1753893284,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日00时34分，Ocugen, Inc.股票出现波动，股价快速上涨6.80%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Replimune Group, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Tnf Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Replimune Group, Inc.较为活跃，换手率分别为401.58%、213.16%、187.48%，振幅较大的相关个股有Replimune Group, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为55.33%、53.86%、47.44%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731003444a46beb5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731003444a46beb5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN","BK4568","BK4139","BK4563"],"gpt_icon":1},{"id":"2555706750","title":"Ocugen, Inc.盘中异动 临近收盘急速下挫5.50%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555706750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555706750?lang=zh_cn&edition=full","pubTime":"2025-07-29 03:32","pubTimestamp":1753731165,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日03时32分，Ocugen, Inc.股票出现波动，股价快速跳水5.50%。截至发稿，该股报1.03美元/股，成交量278.139万股，换手率0.95%，振幅7.34%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072903324594bfe708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072903324594bfe708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","OCGN","BK4563"],"gpt_icon":0},{"id":"2550765556","title":"Ocugen, Inc.盘中异动 股价大涨5.24%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550765556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550765556?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:50","pubTimestamp":1752069048,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时50分，Ocugen, Inc.股票出现异动，股价大幅上涨5.24%。截至发稿，该股报1.11美元/股，成交量82.3154万股，换手率0.28%，振幅3.81%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215048a69f9456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215048a69f9456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN","BK4563","BK4139","BK4568"],"gpt_icon":0},{"id":"2549407559","title":"Ocugen, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549407559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549407559?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:25","pubTimestamp":1751905555,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时25分，Ocugen, Inc.股票出现波动，股价大幅跳水5.07%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为5636.40%、1199.10%、872.17%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、233.18%、84.08%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708002555a69b52e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708002555a69b52e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCGN","BK4568","BK4563"],"gpt_icon":1},{"id":"2547332015","title":"Ocugen, Inc.盘中异动 早盘股价大跌6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547332015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547332015?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:09","pubTimestamp":1751296159,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日23时09分，Ocugen, Inc.股票出现波动，股价急速下挫6.03%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为3902.31%、306.49%、101.44%，振幅较大的相关个股有Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为117.82%、56.94%、50.00%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063023092095316700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063023092095316700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","OCGN","BK4568","BK4139"],"gpt_icon":0},{"id":"2518126273","title":"Ocugen, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518126273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518126273?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615429,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分，Ocugen, Inc.股票出现异动，股价大幅跳水5.03%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为674.24%、343.91%、93.91%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Pmgc Holdings Inc.，振幅分别为41.36%、40.24%、32.14%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022034998a2a58a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022034998a2a58a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","OCGN","BK4563"],"gpt_icon":0},{"id":"2518281638","title":"Ocugen, Inc.2024财年实现净利润-54.05百万美元，同比增加14.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518281638?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536046,"startTime":"0","endTime":"0","summary":"3月10日，Ocugen, Inc.公布财报，公告显示公司2024财年净利润为-54.05百万美元，同比增加14.32%；其中营业收入为4.06百万美元，同比减少32.78%，每股基本收益为-0.20美元。从资产负债表来看，Ocugen, Inc.总负债53.71百万美元，其中短期债务1.85百万美元，资产负债比为1.56，流动比率为2.86。机构评级：截至2025年3月10日，当前有4家机构对Ocugen, Inc.目标价做出预测，其中目标均价为6.75美元，其中最低目标价为4.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000112a2689808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000112a2689808&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN"],"gpt_icon":1},{"id":"2517157509","title":"Chardan Capital：维持Ocugen(OCGN.US)评级，由买入调整至买入评级, 目标价由6.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157509","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517157509?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:22","pubTimestamp":1741267337,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持Ocugen(OCGN.US)评级，由买入调整至买入评级, 目标价由6.00美元调整至7.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06212248574267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OCGN"],"gpt_icon":0},{"id":"2517044944","title":"Ocugen, Inc.盘中异动 股价大跌5.02%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517044944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517044944?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:37","pubTimestamp":1741192666,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时37分，Ocugen, Inc.股票出现异动，股价大幅下挫5.02%。截至发稿，该股报0.560美元/股，成交量173.376万股，换手率0.60%，振幅6.61%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003746abe9d733&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003746abe9d733&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4563","OCGN"],"gpt_icon":1},{"id":"1138464321","title":"Ocugen 2024年第四季度GAAP每股亏损$(0.05)符合预期，营收$764,000超出$300,000预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1138464321","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138464321?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:14","pubTimestamp":1741176882,"startTime":"0","endTime":"0","summary":"Ocugen报告称，公司季度每股亏损$，符合分析师一致预期。这与去年同期每股亏损$相比下降了25%。公司报告季度营收为$764,000千美元，超出分析师一致预期的$300,000千美元，增幅达154.67%。以上内容来自Benzinga Earnings专栏，原文如下：$Ocugen$  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 25 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $764.000 thousand which beat the analyst consensus estimate of $300.000 thousand by 154.67 percent.  This is a 45.78 percent decrease over sal","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ocugen 2024年第四季度GAAP每股亏损$(0.05)符合预期，营收$764,000超出$300,000预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCGN"],"gpt_icon":1},{"id":"2516652894","title":"Ocugen, Inc.盘中异动 快速跳水5.09%报0.619美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652894?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:28","pubTimestamp":1741026501,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时28分，Ocugen, Inc.股票出现波动，股价急速跳水5.09%。截至发稿，该股报0.619美元/股，成交量213.938万股，换手率0.74%，振幅7.01%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022821abe677b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022821abe677b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4563","OCGN"],"gpt_icon":0},{"id":"2514138579","title":"Ocugen, Inc.盘中异动 股价大涨5.20%报0.642美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514138579?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:36","pubTimestamp":1740666971,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时36分，Ocugen, Inc.股票出现波动，股价大幅上涨5.20%。截至发稿，该股报0.642美元/股，成交量74.168万股，换手率0.25%，振幅4.49%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223611a2567b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223611a2567b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","OCGN","BK4563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocugen.com","stockEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.1949},{"period":"3month","weight":-0.0342},{"period":"6month","weight":0.4328},{"period":"1year","weight":0.7318},{"period":"ytd","weight":0.7516}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocugen, Inc.是根据马萨诸塞州的联邦法律注册成立于2000年6月28日，并在马萨诸塞州沃尔瑟姆进行主要业务运营。该公司是一家生物技术公司，专注于发现、开发新型基因和细胞疗法以及疫苗并将其商业化，这些疗法和疫苗可以改善健康并为全球患者带来希望。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":0.078588},{"month":2,"riseRate":0.363636,"avgChangeRate":0.468758},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.024731},{"month":4,"riseRate":0.454545,"avgChangeRate":0.068726},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.04653},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.026339},{"month":7,"riseRate":0.545455,"avgChangeRate":0.125195},{"month":8,"riseRate":0.363636,"avgChangeRate":0.060461},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.186205},{"month":10,"riseRate":0.363636,"avgChangeRate":0.007831},{"month":11,"riseRate":0.272727,"avgChangeRate":-0.198584},{"month":12,"riseRate":0.545455,"avgChangeRate":0.387523}],"exchange":"NASDAQ","name":"Ocugen","nameEN":"Ocugen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocugen(OCGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocugen(OCGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocugen,OCGN,Ocugen股票,Ocugen股票老虎,Ocugen股票老虎国际,Ocugen行情,Ocugen股票行情,Ocugen股价,Ocugen股市,Ocugen股票价格,Ocugen股票交易,Ocugen股票购买,Ocugen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocugen(OCGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocugen(OCGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}